Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
F. Cardoso
Based on 37 articles published since 2009
(Why 37 articles?)
||||
Expertise Level
The expertise of F. Cardoso ranks in the
  • Top 0.042%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 37 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Lisboa      
2018
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Pubmed 28929359
  • Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain. Electronic address: · Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milan, European Institute of Oncology, Italy. · Surgical Oncologist, Guy's Hospital, London, Honorary Senior Lecturer King's College, London, UK. · Department of Radiation Oncology, Marie Curie Professor Paris Science & Lettres, Institut Curie, Paris, France. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Vall d´Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 30056250
  • Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Organisation for Research and Treatment of Cancer- Breast Cancer Group, Toronto, Canada. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · University of Edinburgh, Edinburgh, UK. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Dutch Breast Cancer Research Group (BOOG), The Netherlands. · Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Pathology, University of Washington, Seattle, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Swedish Association of Breast Oncologists (SABO), Lund University, Lund, Sweden. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. · Breast Cancer Genomics and Proteomics Lab, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York. · Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York. · Weill Cornell Medical College, New York. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Hospital Network Antwerp (ZNA), Antwerp, Belgium. · Department of General Medical Oncology, UZ Leuven, Leuven, Belgium. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Specialist Hospital, St. Wojciech, Gdansk, Poland. · Breast Surgical Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Switzerland. · All Ireland Cooperative Oncology Research Group (ICORG), Ireland. · Department of Oncology, Mayo Clinic, Rochester, USA. · Dana-Farber Cancer Institute, Boston, USA. · Department of Oncology, Västmanlands Hospital, Västerås, Sweden. · Swedish Association of Breast Oncologists (SABO), Sweden. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · University of Washington, Seattle, USA. · Department of Oncology, Cheltenham General Hospital, UK. · Global Academic Programs, University of Texas MD Anderson Cancer Center, Houston, USA. · Breast International Group, Brussels, Belgium. · Departments of Health Services Research and Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 29092024
  • Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Institut Jules Bordet, Bruxelles, Belgium. · Tumor and Breast Center ZeTuP, St Gallen, Switzerland. · Breast Center, Kantonsspital St. Gallen, St Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 29045519
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: · Medical Oncology, Galliera Hospital, Genoa, Italy. · Pubmed 27989669
  • Clinical Research Centre, St. Vincent's University Hospital, Dublin and UCD School of Medicine, UCD Conway Institute, University College Dublin, Dublin 4, Ireland. Electronic address: · Breast Center of the University of Munich, Munich, Germany. · Department of Pathology, Atrium Heerlen Medical Centre, Heerlen, The Netherlands. · Laboratory of Biochemistry, Hospital Clinic, Barcelona, Spain. · Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Pisa, Italy. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal. · Pubmed 28259011
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Albert Schweitzer Hospital, Department of Surgery, Dordrecht, The Netherlands. · Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Medical Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28214658
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. · School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Breast Cancer Unit, Ramon y Cajal University Hospital, Madrid. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Internal Medicine, NK Basile Cancer Institute American University of Beirut Medical Center, Beirut, Lebanon. · Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Chief Executive Officer, American Society of Clinical Oncology, Alexandria, USA. · Center of Breast Oncology, Cancer Institute Hospital, Koto-Ku, Tokyo, Japan. · Division of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Stanford University, Stanford, USA. · Breast Unit, Royal Marsden Hospital, London, UK. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Pubmed 27831505
2016
  • Division of Oncology and the Dr Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Vall d`Hebron University Hospital Institut d'Oncologia, Barcelona, Spain. · School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Pubmed 27664246
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Europa Donna Cyprus, Nicosia, Cyprus. · Breast Oncology Center, Cancer Institute Hospital, Tokyo, Japan. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Diagnostic Radiology, Lund University, Malmö, Sweden. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Pubmed 26314782
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters (BIG Aisbl), Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 25315501
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
2012
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 22425534
2012
  • Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 22987969
Probable:    Miscellaneous institutions in Toronto      
2018
  • Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Organisation for Research and Treatment of Cancer- Breast Cancer Group, Toronto, Canada. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · University of Edinburgh, Edinburgh, UK. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Dutch Breast Cancer Research Group (BOOG), The Netherlands. · Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Pathology, University of Washington, Seattle, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Swedish Association of Breast Oncologists (SABO), Lund University, Lund, Sweden. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. · Breast Cancer Genomics and Proteomics Lab, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York. · Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York. · Weill Cornell Medical College, New York. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Hospital Network Antwerp (ZNA), Antwerp, Belgium. · Department of General Medical Oncology, UZ Leuven, Leuven, Belgium. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Specialist Hospital, St. Wojciech, Gdansk, Poland. · Breast Surgical Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Switzerland. · All Ireland Cooperative Oncology Research Group (ICORG), Ireland. · Department of Oncology, Mayo Clinic, Rochester, USA. · Dana-Farber Cancer Institute, Boston, USA. · Department of Oncology, Västmanlands Hospital, Västerås, Sweden. · Swedish Association of Breast Oncologists (SABO), Sweden. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · University of Washington, Seattle, USA. · Department of Oncology, Cheltenham General Hospital, UK. · Global Academic Programs, University of Texas MD Anderson Cancer Center, Houston, USA. · Breast International Group, Brussels, Belgium. · Departments of Health Services Research and Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 29092024
Probable:    Miscellaneous institutions in Brasilia      
2014
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 37 total) written by F. Cardoso about Breast Neoplasms:

  • Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. 2018
  • Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back? 2018
  • Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. 2018
  • Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Editorial: Why are guidelines not followed in clinical practice? 2017
  • Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). 2017
  • An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint 2017
  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. 2017
Show List of Full Article Records
Google Searches

Learn more about F. Cardoso using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Lisboa
Miscellaneous institutions in Toronto
Miscellaneous institutions in Brasilia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Lisboa
2018
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Pubmed 28929359
  • Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain. Electronic address: · Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Division of Early Drug Development for Innovative Therapy, Department of Oncology and Hemato-Oncology, University of Milan, European Institute of Oncology, Italy. · Surgical Oncologist, Guy's Hospital, London, Honorary Senior Lecturer King's College, London, UK. · Department of Radiation Oncology, Marie Curie Professor Paris Science & Lettres, Institut Curie, Paris, France. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Vall d´Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 30056250
  • Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Organisation for Research and Treatment of Cancer- Breast Cancer Group, Toronto, Canada. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · University of Edinburgh, Edinburgh, UK. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Dutch Breast Cancer Research Group (BOOG), The Netherlands. · Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Pathology, University of Washington, Seattle, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Swedish Association of Breast Oncologists (SABO), Lund University, Lund, Sweden. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. · Breast Cancer Genomics and Proteomics Lab, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York. · Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York. · Weill Cornell Medical College, New York. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Hospital Network Antwerp (ZNA), Antwerp, Belgium. · Department of General Medical Oncology, UZ Leuven, Leuven, Belgium. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Specialist Hospital, St. Wojciech, Gdansk, Poland. · Breast Surgical Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Switzerland. · All Ireland Cooperative Oncology Research Group (ICORG), Ireland. · Department of Oncology, Mayo Clinic, Rochester, USA. · Dana-Farber Cancer Institute, Boston, USA. · Department of Oncology, Västmanlands Hospital, Västerås, Sweden. · Swedish Association of Breast Oncologists (SABO), Sweden. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · University of Washington, Seattle, USA. · Department of Oncology, Cheltenham General Hospital, UK. · Global Academic Programs, University of Texas MD Anderson Cancer Center, Houston, USA. · Breast International Group, Brussels, Belgium. · Departments of Health Services Research and Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 29092024
  • Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Institut Jules Bordet, Bruxelles, Belgium. · Tumor and Breast Center ZeTuP, St Gallen, Switzerland. · Breast Center, Kantonsspital St. Gallen, St Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan, Italy. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 29045519
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: · Medical Oncology, Galliera Hospital, Genoa, Italy. · Pubmed 27989669
  • Clinical Research Centre, St. Vincent's University Hospital, Dublin and UCD School of Medicine, UCD Conway Institute, University College Dublin, Dublin 4, Ireland. Electronic address: · Breast Center of the University of Munich, Munich, Germany. · Department of Pathology, Atrium Heerlen Medical Centre, Heerlen, The Netherlands. · Laboratory of Biochemistry, Hospital Clinic, Barcelona, Spain. · Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Pisa, Italy. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal. · Pubmed 28259011
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Albert Schweitzer Hospital, Department of Surgery, Dordrecht, The Netherlands. · Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Medical Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28214658
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
  • Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands. · Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Department of Product Development and Support, Agendia, Amsterdam, The Netherlands. · Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: · Pubmed 28477490
  • Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. · School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Breast Cancer Unit, Ramon y Cajal University Hospital, Madrid. · Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Internal Medicine, NK Basile Cancer Institute American University of Beirut Medical Center, Beirut, Lebanon. · Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia. · Chief Executive Officer, American Society of Clinical Oncology, Alexandria, USA. · Center of Breast Oncology, Cancer Institute Hospital, Koto-Ku, Tokyo, Japan. · Division of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Stanford University, Stanford, USA. · Breast Unit, Royal Marsden Hospital, London, UK. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Pubmed 27831505
2016
  • Division of Oncology and the Dr Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Vall d`Hebron University Hospital Institut d'Oncologia, Barcelona, Spain. · School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Pubmed 27664246
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. · Europa Donna Cyprus, Nicosia, Cyprus. · Breast Oncology Center, Cancer Institute Hospital, Tokyo, Japan. · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand EA 4677 Université d'Auvergne, Clermont-Ferrand, France. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Diagnostic Radiology, Lund University, Malmö, Sweden. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Pubmed 26314782
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters (BIG Aisbl), Brussels, Belgium. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 25315501
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
2012
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 22425534
2012
  • Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Pubmed 22987969
Miscellaneous institutions in Toronto
2018
  • Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · European Organisation for Research and Treatment of Cancer- Breast Cancer Group, Toronto, Canada. · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada. · University of Edinburgh, Edinburgh, UK. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. · Dutch Breast Cancer Research Group (BOOG), The Netherlands. · Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Pathology, University of Washington, Seattle, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Swedish Association of Breast Oncologists (SABO), Lund University, Lund, Sweden. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. · Breast Cancer Genomics and Proteomics Lab, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York. · Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York. · Weill Cornell Medical College, New York. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Hospital Network Antwerp (ZNA), Antwerp, Belgium. · Department of General Medical Oncology, UZ Leuven, Leuven, Belgium. · Beatson West of Scotland Cancer Centre, Glasgow, UK. · Specialist Hospital, St. Wojciech, Gdansk, Poland. · Breast Surgical Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Switzerland. · All Ireland Cooperative Oncology Research Group (ICORG), Ireland. · Department of Oncology, Mayo Clinic, Rochester, USA. · Dana-Farber Cancer Institute, Boston, USA. · Department of Oncology, Västmanlands Hospital, Västerås, Sweden. · Swedish Association of Breast Oncologists (SABO), Sweden. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · University of Washington, Seattle, USA. · Department of Oncology, Cheltenham General Hospital, UK. · Global Academic Programs, University of Texas MD Anderson Cancer Center, Houston, USA. · Breast International Group, Brussels, Belgium. · Departments of Health Services Research and Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 29092024
Miscellaneous institutions in Brasilia
2014
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
European School of Oncology
2012
2011
14 Other Locations Show
Yearly article counts 04813656310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.